Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors

Katherine M. Byrd, Chitra Subramanian, Jacqueline Sanchez, Hashim F. Motiwala, Weiya Liu, Mark S. Cohen, Jeffrey Holzbeierlein, Brian S.J. Blagg

Research output: Contribution to journalArticlepeer-review

Abstract

Development of heat shock protein 90 (Hsp90) C-terminal inhibitors has emerged as an exciting strategy for the treatment of cancer. Previous efforts have focused on modifications to the natural products novobiocin and coumermycin. Moreover, variations in both the sugar and amide moieties have been extensively studied, whereas replacements for the coumarin core have received less attention. Herein, 24 cores were synthesized with varying distances and angles between the sugar and amide moieties. Compounds that exhibited good anti-proliferative activity against multiple cancer cell lines and Hsp90 inhibitory activity, were those that placed the sugar and amide moieties between 7.7 and 12.1 Å apart along with angles of 180°.

Original languageEnglish (US)
Pages (from-to)6921-6931
Number of pages11
JournalChemistry - A European Journal
Volume22
Issue number20
DOIs
StatePublished - May 10 2016
Externally publishedYes

Keywords

  • antitumor agents
  • C-terminal inhibitors
  • Hsp90
  • luciferase refolding
  • medicinal chemistry

ASJC Scopus subject areas

  • Catalysis
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors'. Together they form a unique fingerprint.

Cite this